Details for 2018744888
Up to date per 01.04.2026
Actions
Details for 2018744888
Granted/Registered
European Patent
04.12.2019 A
19.04.2023 B1
27.01.2017
US
201762451391 P
A61K 38/37 20060101AFI20200910BHEP
Owner
Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, OsakaJP
Representative
Authorized Recipients
Paul CosmoviciGumpendorfer Straße 1421060 WienAT
Inventor
NELSON, Michael300 Shire Way Lexington, MA 02421US
PICHLER, Roman300 Shire Way Lexington, MA 02421US
SPOTTS, Gerald17057 Adlon Road Encino, CA 91436US
Information about Fees